Friday, October 23, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Maintains Neutral Rating on AvalonBay Communities with Lowered Price Target

Elaine Mendonca by Elaine Mendonca
February 28, 2024
in Breaking News
0
Real Estate Investment Markets and money
0
SHARES
39
VIEWS
Share on FacebookShare on Twitter

Vikram Malhotra, an analyst at Mizuho, has decided to keep a Neutral rating on AvalonBay Communities (NYSE: AVB) and has slightly decreased the price target to $185 from $188. This adjustment follows a recent increase in the price target from $176 to $188 on January 10th. It is important to mention that the average 12-month price target for AvalonBay Communities is currently $194.2, as indicated by evaluations from 10 financial analysts.

AvalonBay Communities Inc. (AVB) Stock Sees Slight Increase on February 28, 2024: Factors Investors Should Consider

On February 28, 2024, AvalonBay Communities Inc. (AVB) saw a slight increase in its stock performance. The stock closed at $174.37, marking a $0.75 increase from the previous market close, representing a 0.43% rise. Additionally, in after-hours trading, the stock continued to climb, rising by an additional $0.54.

Investors may want to consider the factors contributing to AVB’s recent price momentum. This could include company-specific news, industry trends, or broader market conditions. By staying informed and conducting thorough research, investors can make more informed decisions about their investment strategies.

AVB Stock Reports Mixed Performance in 2024 with Revenue Growth and Net Income Decrease

AVB stock had a mixed performance on February 28, 2024, as the company reported its financial results for the past year and the fourth quarter. According to data from CNN Money, AVB’s total revenue for the year stood at $2.82 billion, representing a 7.04% increase from the previous year. However, total revenue for the fourth quarter was reported at $718.65 million, remaining flat compared to the previous quarter. AVB’s net income for the year was $927.16 million, marking an 18.29% decrease from the previous year. However, net income for the fourth quarter was $241.53 million, showing a significant increase of 40.65% from the previous quarter. Earnings per share (EPS) for the year were reported at $6.55, reflecting a 19.25% decrease from the previous year. EPS for the fourth quarter remained flat at $1.70. Investors and analysts will likely be closely monitoring AVB’s performance in the coming quarters to see if the company can sustain its revenue growth and improve its profitability.

Tags: AVB
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finance_Assets (2)

Analyst Maintains Neutral Rating on Equity Residential with Adjusted Price Target

Real Estate Investment Markets and money

Analysts Maintain Neutral Rating on MidAmerica Apartment Communities with Adjusted Price Targets

Finance_Assets (2)

Ambarellas Stock Soars After Exceeding Expectations in Q4 FY24

Recommended

BioNTech Stock

BioNTech Investors Face Legal Challenge Following CureVac Acquisition

10 months ago
Eli Lilly Stock

Eli Lilly Faces Pricing Pressure as New Regulations Force Strategic Shift

1 year ago
MMM stock news

WestPark Capital Downgrades Palo Alto Networks to Hold Rating Despite Companys Resolute Stance

3 years ago
Inmune Bio Stock

Inmune Bio Navigates Strategic Shift Amid Market Pressures

1 year ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum DroneShield Eli Lilly FALLBACK Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Robinhood Rocket Lab USA Salesforce Strategy Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Most Stocks Rose While the Index Fell: Earnings Week Is the Test

Tesla Jumps on a Roadster as Tech Slips Into the Weekend

CoreWeave’s Bonds Flash Red as Strong Earnings Fall Flat

Hot Core CPI Sorts the Stocks: ASML Delivers, J&J Stumbles

Goldman Delivers as Memory Stocks Slide Ahead of CPI

Optics Run Hot as Chip Leaders Pause for Breath

Trending

Bitcoin Stock
Newsletter

Lam, Tesla and Meta Clear the Bar and Still Get Sold

by Stephanie Dugan
October 22, 2026
0

Dear readers, Wednesday's open question got its answer overnight. Lam Research told investors that global spending on...

Danaher Stock

Beat Estimates, Lose Ground: Guidance Now Drives Earnings Season

October 21, 2026
Mastercard Stock

The AI Rally Needs Cheap Money, and Cheap Money Is Scarce

October 20, 2026
Meta Stock

Most Stocks Rose While the Index Fell: Earnings Week Is the Test

October 18, 2026
Tesla Stock

Tesla Jumps on a Roadster as Tech Slips Into the Weekend

October 16, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Lam, Tesla and Meta Clear the Bar and Still Get Sold
  • Beat Estimates, Lose Ground: Guidance Now Drives Earnings Season
  • The AI Rally Needs Cheap Money, and Cheap Money Is Scarce

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com